Literature DB >> 17587490

Cardiac BNP gene activation by angiotensin II in vivo.

Theresa Majalahti1, Maria Suo-Palosaari, Balázs Sármán, Nina Hautala, Sampsa Pikkarainen, Heikki Tokola, Olli Vuolteenaho, Jun Wang, Pierre Paradis, Mona Nemer, Heikki Ruskoaho.   

Abstract

The transcription factors involved in the activation of cardiac gene expression by angiotensin II (Ang II) in vivo are not well understood. Here we studied the contribution of transcriptional elements to the activation of the cardiac B-type natriuretic peptide (BNP) gene promoter by Ang II in conscious rats and in angiotensin II type 1 receptor (AT1R) transgenic mice. Rat BNP luciferase reporter gene constructs were injected into the left ventricular wall. The mean luciferase activity was 1.8-fold higher (P<0.05) in the ventricles of animals subjected to 2-week Ang II infusion as compared with vehicle infusion. Our results indicate that GATA binding sites at -90 and -81 in the rat BNP promoter are essential for the in vivo response to Ang II. The GATA factor binding to these sites is GATA-4. BNP mRNA levels and GATA-4 binding activity are also increased in the hypertrophied hearts of aged AT1R transgenic mice.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17587490     DOI: 10.1016/j.mce.2007.05.003

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  12 in total

1.  Effects of small platform catheter-based left ventricular assist device support on regional myocardial signal transduction.

Authors:  Keshava Rajagopal; Progyaparamita Saha; Isa Mohammed; Pablo G Sanchez; Tieluo Li; Zhongjun J Wu; Bartley P Griffith
Journal:  J Thorac Cardiovasc Surg       Date:  2015-08-15       Impact factor: 5.209

2.  Angiotensin1-9 antagonises pro-hypertrophic signalling in cardiomyocytes via the angiotensin type 2 receptor.

Authors:  M Flores-Muñoz; N J Smith; C Haggerty; G Milligan; S A Nicklin
Journal:  J Physiol       Date:  2010-12-20       Impact factor: 5.182

3.  The natriuretic peptide/guanylyl cyclase--a system functions as a stress-responsive regulator of angiogenesis in mice.

Authors:  Michaela Kuhn; Katharina Völker; Kristine Schwarz; Javier Carbajo-Lozoya; Ulrich Flögel; Christoph Jacoby; Jörg Stypmann; Martin van Eickels; Stepan Gambaryan; Michael Hartmann; Matthias Werner; Thomas Wieland; Jürgen Schrader; Hideo A Baba
Journal:  J Clin Invest       Date:  2009-07       Impact factor: 14.808

4.  GATA4-targeted compound exhibits cardioprotective actions against doxorubicin-induced toxicity in vitro and in vivo: establishment of a chronic cardiotoxicity model using human iPSC-derived cardiomyocytes.

Authors:  S Tuuli Karhu; Sini M Kinnunen; Marja Tölli; Mika J Välimäki; Zoltán Szabó; Virpi Talman; Heikki Ruskoaho
Journal:  Arch Toxicol       Date:  2020-03-17       Impact factor: 5.153

Review 5.  Structure and function of the Nppa-Nppb cluster locus during heart development and disease.

Authors:  Joyce Man; Phil Barnett; Vincent M Christoffels
Journal:  Cell Mol Life Sci       Date:  2018-01-04       Impact factor: 9.261

6.  Rutin Modulates MAPK Pathway Differently from Quercetin in Angiotensin II-Induced H9c2 Cardiomyocyte Hypertrophy.

Authors:  Hawa Nordin Siti; Juriyati Jalil; Ahmad Yusof Asmadi; Yusof Kamisah
Journal:  Int J Mol Sci       Date:  2021-05-11       Impact factor: 5.923

7.  ACE-inhibitors, beta-blockers or the combination in heart failure: is it just an A-B-C ? : editorial to: effects of beta-blockade and ACE inhibition on B-type natriuretic peptides in stable patients with systolic heart failure by Rosenberg et al.

Authors:  Rudolf A de Boer; Dirk J van Veldhuisen
Journal:  Cardiovasc Drugs Ther       Date:  2008-04-17       Impact factor: 3.727

8.  Quercetin inhibits left ventricular hypertrophy in spontaneously hypertensive rats and inhibits angiotensin II-induced H9C2 cells hypertrophy by enhancing PPAR-γ expression and suppressing AP-1 activity.

Authors:  Lei Yan; Ji Dong Zhang; Bo Wang; Yi Jing Lv; Hong Jiang; Gui Lin Liu; Yun Qiao; Ming Ren; Xue Feng Guo
Journal:  PLoS One       Date:  2013-09-10       Impact factor: 3.240

9.  Angiotensin II Induced Cardiac Dysfunction on a Chip.

Authors:  Renita E Horton; Moran Yadid; Megan L McCain; Sean P Sheehy; Francesco S Pasqualini; Sung-Jin Park; Alexander Cho; Patrick Campbell; Kevin Kit Parker
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240

10.  Fibulin-2 is essential for angiotensin II-induced myocardial fibrosis mediated by transforming growth factor (TGF)-β.

Authors:  Shaukat A Khan; Hailong Dong; Jennifer Joyce; Takako Sasaki; Mon-Li Chu; Takeshi Tsuda
Journal:  Lab Invest       Date:  2016-04-25       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.